Two Mpox cases confirmed in Lilongwe
Health authorities through the Public Health Institute of Malawi (PHIM) have confirmed two Mpox cases detected in Lilongwe.
A statement signed by Secretary for Health Samson Mndolo explains that this comes from the first suspected case reported by Bwaila Hospital on 20 March this year and the second case reported on 9 April 2025.
Samples were collected from the suspected cases for laboratory investigations at the National Reference Laboratory in Lilongwe, and the results came out positive on 16 April.
Mpox is a zoonotic viral disease transmitted from animals to humans and from humans to humans, characterized by fever and rash.
It spreads through contact with respiratory droplets, lesion material, body fluids, contaminated materials, and surfaces that enter the body through the respiratory tract, mucous membranes, and broken skin.
Children, pregnant women, people with underlying immune deficiencies, and people with multiple sex partners have a higher risk of getting the disease.
According to health experts, while there is no specific treatment for Mpox, treatment remains supportive and symptomatic.
Mndolo has since advised the public not to panic as the situation is under control, and to take preventive and control measures as the disease has the potential to affect more people.
”Mpox can be prevented by avoiding close or skin-to-skin contact with suspected or confirmed Mpox cases, observing good hygiene, and using condoms during sexual activity,” explained Mndolo.
The statement says the ministry is working closely with Lilongwe District Council, the World Health Organization, the CDC USA, the Africa CDC, and other partners to ensure proper surveillance, response, and timely treatment of cases.
About The Author
